PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI/SNF mutant tumors
Authors:
- 30 October 2017
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (46) , 12249-12254
Abstract
Significance: Targeting epigenetic dependencies caused by mutations in chromatin-modifying enzymes represents a novel therapeutic approach in cancer. Notably, cancers harboring mutations in the SNF5 subunit of the SWI/SNF chromatin remodeling complex have been shown to be susceptible to small-molecule inhibitors of the EZH2 histone methyltransferase that are currently in clinical development. We demonstrate that EZH2 inhibition can be effective in SMARCA4 mutant cancers that concurrently transcriptionally silence the paralog helicase SMARCA2. SMARCA2 is directly suppressed by EZH2, and SMARCA2 expression levels predict EZH2 inhibitor activity in other SWI/SNF mutant contexts, including ARID1A mutant tumors. These data provide insight into the utility of EZH2 inhibitors in SWI/SNF mutant tumors and have important implications regarding predictive diagnostics.Keywords
This publication has 37 references indexed in Scilit:
- SMARCA4 and SMARCA2 deficiency in non–small cell lung cancer: immunohistochemical survey of 316 consecutive specimensAnnals of Diagnostic Pathology, 2017
- Frequent co‐inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumoursHistopathology, 2014
- The silencing of the SWI/SNF subunit and anticancer gene BRM in Rhabdoid tumorsOncotarget, 2014
- Residual Complexes Containing SMARCA2 (BRM) Underlie the Oncogenic Drive of SMARCA4 (BRG1) MutationMolecular and Cellular Biology, 2014
- Targeted Knockout of BRG1 Potentiates Lung Cancer DevelopmentCancer Research, 2008
- Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.2003
- Transcriptional Specificity of Human SWI/SNF BRG1 and BRM Chromatin Remodeling ComplexesMolecular Cell, 2003
- Cathepsin B Acts as a Dominant Execution Protease in Tumor Cell Apoptosis Induced by Tumor Necrosis FactorJournal of Cell Biology, 2001
- Disruption of Ini1 Leads to Peri-Implantation Lethality and Tumorigenesis in MiceMolecular and Cellular Biology, 2001
- Truncating mutations of hSNF5/INI1 in aggressive paediatric cancerNature, 1998